Investment Summary

Ampersand Capital Partners Invests In Sterling Medical Devices

On June 23, 2022, growth capital firm Ampersand Capital Partners invested in technology hardware company Sterling Medical Devices

Investment Highlights
  • This is Ampersand Capital Partners’ 1st transaction in the Technology Hardware sector.
  • This is Ampersand Capital Partners’ 56th transaction in the United States.
  • This is Ampersand Capital Partners’ 7th transaction in New Jersey.

Investment Summary

Date 2022-06-23
Target Sterling Medical Devices
Sector Technology Hardware
Investor(s) Ampersand Capital Partners
Deal Type Growth Capital

Target

Sterling Medical Devices

Moonachie, New Jersey, United States
website
Sterling Medical Devices is a provider of custom electromechanical and software solutions for the medical device industry. Sterling Medical Devices was founded in 1998 and is based in Moonachie, New Jersey.

Search 171,517 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

website


Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
SizeLarge
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


DEAL STATS #
Overall 64 of 64
Sector (Technology Hardware) 1 of 1
Type (Growth Capital) 22 of 22
State (New Jersey) 7 of 7
Country (United States) 56 of 56
Year (2022) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-18 Syft

Christchurch , New Zealand

Syft develops SIFT-MS, a form of direct mass spectrometry that analyses volatile organic compounds (VOCs) in the air with typical detection limits at parts-per-trillion level (by volume; pptv). Syft was founded in 2002 and is based in Christchurch, New Zealand.

Buy -